Curation of rheumatic arthritis patients: modern recommendations and real clinical practice
- Авторлар: Chichasova N.V.1, Igolkina E.V.1, Imametdinova G.R.1, Nasonov E.L.2
-
Мекемелер:
- Federal State Autonomous Education Institution of Higher Education I.M. Sechenov «First Moscow State Medical University Under the Ministry of Health of the Russian Federation»
- V.A. Nasonova institute of rheumatology FSBI
- Шығарылым: № 4 (2018)
- Беттер: 35-42
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/279385
- ID: 279385
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
Natalya Chichasova
Federal State Autonomous Education Institution of Higher Education I.M. Sechenov «First Moscow State Medical University Under the Ministry of Health of the Russian Federation»
Email: KafedraRheum@yandex.ru
MD, professor of the Department of rheumathology
Elena Igolkina
Federal State Autonomous Education Institution of Higher Education I.M. Sechenov «First Moscow State Medical University Under the Ministry of Health of the Russian Federation»
Email: KafedraRheum@yandex.ru
PhD, associate professor of the Department
Gyuzel Imametdinova
Federal State Autonomous Education Institution of Higher Education I.M. Sechenov «First Moscow State Medical University Under the Ministry of Health of the Russian Federation»
Email: KafedraRheum@yandex.ru
PhD, associate professor of the Department of rheumatology
Evgeny Nasonov
V.A. Nasonova institute of rheumatology FSBI
Email: sokrat@irramn.ru
academician of RAS, MD, professor, president of the Association of rheumatologists of Russia, chief supernumerary rheumatologist of the Ministry of Healthcare of Russia, research advisor
Әдебиет тізімі
- Насонова В.А., Фоломеева О.М., Эрдес Ш. Социальная значимость заболеваний ревматического круга в России. Научнопрактическая ревматология. 2002; 40(1): 5-8.
- Aletaha D., Neogi T., Silman A.J. et al. 2010 Rheumatoid Arthritis classification criteria/ An American College of Rheumatology / European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
- Smolen J.S., Aletaha D., Bijlsma J.W. et al. Treating rheumatoid arthritis to target: recommendations of an inter-national task force. Ann. Rheum. Dis. 2010; 69: 631-7.
- Smolen J.S., Landewe R., Bijlsma J. et al. EULAR recommendations for the management of rheumatoid arthritiswith synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann. Rheum. Dis. 2017; 76: 960-77.
- Российские клинические рекомендации. Ревматология. Под ред. академика РАН Е.Л. Насонова. «ГЭОТАР-Медиа», 2017. С. 17-57.
- Breedveld F.C., Emery P., Keystone E., Patel K., Furst D.E., Kalden J.R., St Clair E.W., Weisman M., Smolen O., Lipsky P.E., Maini R.N. Infliximab in active early rheumatoid arthritis. Ann. Rheum. Dis., 2004; 63: 149-55.
- Jantii J., Kaarela K., Belt E., Kautiainen H.J. Incidence of severe outcome in rheumatoid arthritis during 20 years. J. Rheumatol. 2002; 29: 688-92.
- Van Steenbergen H.W., Aletaha D., Beaart-van de Voorde L.J. et al. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis. Ann. Rheum. Dis. 2017; 76: 491-6.
- Lard L.R., Visser H., Speyer I., vander Horst-Bruinsma I.E., Zwinderman A.H., Breedveld F.C., Hazes J.M. Early versus delayed treatment un patients with recent-onset rheumatoid arthritis: comparison of two cohorts who re-ceived different treatment strategies. Am. J. Med. 2001; 111: 446-51.
- Насонов Е.Л., Каратеев Д.Е., Чичасова Н.В. Новые рекомендации по лечению ревматоидного артрита (EULAR, 2013): место метотрексата. Научно-практическая ревматология. 2014; 52: 8-26.
- Насонов Е.Л. Метотрексат при ревматоидном артрите - 2015: новые факты и идеи. Научно-практическая ревматология. 2015; 53: 421-33.
- Shea B., Swinden M.V., Tanjong Ghogomi E., Ortiz Z., Katchamart W., Rader T., Bombardier C., Wells G.A., Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database Syst. Rev. 2013; 5: CD000951.
- Chatzidionysiou K., Emamikia S., Nam J., Ramiro S., Smolen J., van der Heijde D., Dougados M., Bijlsma J., Burmester G., Scholte M., van Vollenhoven R., Landewé R. Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of The EULAR recommendations for the management of rheumatoid arthritis. Ann. Rheum. Dis. 2017; 76: 1102-7.
- Panoulas V.F., Douglas K.M., Stavropoulos-Kalinoglou A., Metsios G.S., Nightingale P., Kita M.D., Elisaf M.S., Kitas G.D. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. J. Rheumatol. (Oxford) 2008; 47: 72-5.
- Чичасова Н.В., Владимиров С.А., Имаметдинова Г.Р., Иголкина Е.В., Насонов Е.Л. Функциональные исходы ревматоидного артрита при различных способах противовоспалительной терапии. Научно-практическая ревматология. 2010; 48(2): 30-6.
- Schiff M.H., Jaffe J.S., Freundlich B. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥ 15 mg may be overcome with subcutaneous administration. Ann. Rheum. Dis. 2014; 73: 1549-51.
- Prevoo M.L., van ‘t Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joints counts. Arthritis Rheum. 1995; 38: 44-102.
- Bruce B., Fries J.F. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J. Rheumatol. 2003; 30: 167-78.
- Felson D.T., Smolen J.S., Wells G. et al. American College of Rheumatology/European League Against Rheuma-tism Provisional Definition of remission in Rheumatoid Arthritis for clinical trials. Arthritis Rheum. 2011; 63: 573-86.
- Finckh A., Liang M.H., van Herckenrode C.M., de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum. 2006; 55(6): 864-72.
- Чичасова Н.В., Каневская М.З., Имаметдинова Г.Р., Иголкина Е.В., Насонов Е.Л. Отдаленные исходы рев-матоидного артрита в зависимости от сроков начала терапии базисными противовоспалительными препаратами. Научно-практическая ревматология. 2010; 48 (3): 23-30.
- Contreras-Yanez I., Ponce De Leon S., Cabiedes J. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am. J. Med. Sci. 2010; 340: 282-90.
- Pascual-Ramos V., Contreras-Yanez I., Villa A.R., Cabiedes J., Rull-Gabayet M. Medication persistence over 2 years of follow-up in cohort of early rheumatoid arthritis patients: association ship with disease activity and with disability. Arthritis Res. Ther. 2009; 11: R26.
Қосымша файлдар
![](/img/style/loading.gif)